Unravelling the Impact: Pulmonary Side Effects of Anti-Seizure Medications
- 1 January 2025
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Respiratory Medicine Reviews
- Vol. 21 (1) , 29-47
Abstract
Background: Epilepsy is a chronic brain condition affecting over 50 million people worldwide. Several new anti-seizure medications (ASMs) have been introduced to treat epilepsy in recent decades. Objective: Nearby the specific therapeutic action, ASMs, like other types of pharmacotherapy, can produce various side effects. In this review, we shall analyze the different pharmaceutical classes of ASMs, their mechanism of action, and their interaction with the respiratory system. Methods: This manuscript is based on a retrospective review of English publications indexed by Pubmed, UpToDate and datasheets published by the European Medicines Agency and the Food and Drug Administration (FDA), using various terms reminiscent of ASMs and pulmonary function. Results: ASMs act on organism homeostasis in different ways, acting on lung function directly and indirectly and playing a protective or damaging role. A damaging direct lung involvement ranged from infections, hypersensitivity reactions, and respiratory depression to other structured pulmonary diseases. Meanwhile, a damaging indirect effect, might be constituted by pulmonary artery hypertension. On the other hand, a protective effect might be the expression of developmental processing, decreasing airway remodelling in asthma patients, vascular remodelling in pulmonary hypertension and, nonetheless, anti-inflammatory and immunomodulatory actions. Conclusion: An adequate awareness of ASMs effects on the respiratory system seems essential for better managing frail individuals or/and those predisposed to respiratory disorders to improve our patients' clinical outcomes.Keywords
This publication has 155 references indexed in Scilit:
- Efficacy and Safety of Fenfluramine in Epilepsy: A Systematic Review and Meta-analysisNeurology and Therapy, 2023
- Clinical Features, Intensive Care Needs, and Outcome of Carbamazepine Poisoning in ChildrenIndian Journal of Pediatrics, 2022
- Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug–Drug Interactions and TolerabilityCNS Drugs, 2021
- Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox–Gastaut SyndromeCNS Drugs, 2021
- Gabapentin add-on treatment for drug-resistant focal epilepsyCochrane Database of Systematic Reviews, 2021
- Felbamate add-on therapy for drug-resistant focal epilepsyCochrane Database of Systematic Reviews, 2019
- Stiripentol in the Management of EpilepsyCNS Drugs, 2017
- Newer anti-epileptic drugsIndian Pediatrics, 2013
- Treatment of Lennox-Gastaut syndromeCochrane Database of Systematic Reviews, 2013
- Oxcarbazepine for acute affective episodes in bipolar disorderCochrane Database of Systematic Reviews, 2011